Abstract
Neoadjuvant systemic therapy is the standard of care in the treatment of locally advanced breast cancer. Heterogeneity of tumour microenvironment complicates the response to the treatment. Very few studies focus on the response pattern of neoadjuvant chemotherapy in locally advanced breast carcinoma. We aim to hypothesize that breast cancer microenvironment has a heterogeneous pattern. This is prominent when skin is involved and can be attributed to a higher distribution of cancer stem cells on the surface compared to the core and is independent of tumour biology.
Similar content being viewed by others
References
Liu SV, Melstrom L, Yao K, Russell CA, Sener SF (2010) Neoadjuvant therapy for breast cancer. J Surg Oncol 101:283–91
Laboratory of drug targets histopathology, Institute of Cardiology, Lithuanian University of Health Sciences, Sukilėlių Av. 13, LT-50161, Kaunas, Lithuania Life Sciences Center, Vilnius University, Saulėtekio Av. 7, LT-10257, Vilnius, Lithuania
Ellis IO et al (1992) Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 20:479–489
Mukherjee S, Mazumdar M, Chakraborty S, Manna A, Saha S, Khan P et al (2014) Curcumin inhibits breast cancer stem cell migration by amplifying the E-cadherin/b-catenin negative feedback loop. Stem Cell Res Ther 5:116
Hossain DMS, Panda AK, Manna A, Mohanty S, Bhattacharjee P, Bhatta-charyya S et al (2013) FoxP3 acts as a cotranscription factor with STAT3 in tumor-induced regulatory T cells. Immunity 39:1057–1069
Discordant chemosensitivity pattern in T4b lesions is related to morphologic heterogenity and distribution of cancer stem cells in tumor microenvironment Diptendra K Sarkar, A K Manna, A K Singhal; EJSO Volume 47, Issue 05
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics Approval
This study was approved by the ethical committee of our hospital.
Patient Consent
Patients’ informed consents were obtained.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Singhal, A.K., Sarkar, D.K., Manna, A.K. et al. Factors Responsible for Discordant Response to Neoadjuvant Systemic Therapy in T4b Breast Cancer. Indian J Surg 84 (Suppl 3), 703–707 (2022). https://doi.org/10.1007/s12262-021-03084-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12262-021-03084-7